Literature DB >> 3123716

Elastin metabolism of the infrarenal aorta.

J R Cohen1, C Mandell, J B Chang, L Wise.   

Abstract

Aortic tissue elastase and alpha 1-antitrypsin were assayed in 67 patients with different types of infrarenal aortic disease; occlusive disease, elective abdominal aortic aneurysms (AAAs), multiple aneurysms, and ruptured aneurysms. Elastase modified by alpha 1-antitrypsin (elastase/alpha 1-antitrypsin) increased significantly as the type of aortic disease changed from occlusive to aneurysmal disease. Aortic elastase was significantly higher in patients with AAAs, multiple aneurysms, and ruptured AAAs compared with occlusive disease. The alpha 1-antitrypsin, was significantly lower in patients with multiple aneurysms and ruptured AAAs. These data suggest that the ratio between elastase and its major serum inhibitor, alpha 1-antitrypsin, is significantly altered in the aortic wall in different types of infrarenal aortic disease. In addition, the ratio between these two enzyme systems changes in favor of more proteolytic activity as the type of infrarenal disease changes from occlusive to aneurysmal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123716     DOI: 10.1067/mva.1988.avs0070210

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

Review 1.  Biomarkers of AAA progression. Part 1: extracellular matrix degeneration.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-05-26       Impact factor: 32.419

2.  On the inheritance of abdominal aortic aneurysm.

Authors:  P P Majumder; P L St Jean; R E Ferrell; M W Webster; D L Steed
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

3.  Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms.

Authors:  A López-Candales; D R Holmes; S Liao; M J Scott; S A Wickline; R W Thompson
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

4.  Dilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valve.

Authors:  Kadriye Orta Kilickesmez; Okay Abaci; Cuneyt Kocas; Ahmet Yildiz; Aysem Kaya; Baris Okcun; Serdar Kucukoglu
Journal:  Heart Vessels       Date:  2011-06-23       Impact factor: 2.037

5.  Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms.

Authors:  Monica B Pagano; Michel A Bartoli; Terri L Ennis; Dongli Mao; Pamela M Simmons; Robert W Thompson; Christine T N Pham
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-14       Impact factor: 11.205

6.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.

Authors:  R W Thompson; D R Holmes; R A Mertens; S Liao; M D Botney; R P Mecham; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 7.  Abdominal aortic surgery: anesthetic implications.

Authors:  A J Cunningham
Journal:  Yale J Biol Med       Date:  1991 Jul-Aug

Review 8.  A comparative review of the hemodynamics and pathogenesis of cerebral and abdominal aortic aneurysms: lessons to learn from each other.

Authors:  Omar Tanweer; Taylor A Wilson; Eleni Metaxa; Howard A Riina; Hui Meng
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2014-12-30

9.  Biomechanical Restoration Potential of Pentagalloyl Glucose after Arterial Extracellular Matrix Degeneration.

Authors:  Sourav S Patnaik; Senol Piskin; Narasimha Rao Pillalamarri; Gabriela Romero; G Patricia Escobar; Eugene Sprague; Ender A Finol
Journal:  Bioengineering (Basel)       Date:  2019-07-03

10.  Inhibition of early AAA formation by aortic intraluminal pentagalloyl glucose (PGG) infusion in a novel porcine AAA model.

Authors:  Brian O Kloster; Lars Lund; Jes S Lindholt
Journal:  Ann Med Surg (Lond)       Date:  2016-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.